TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T64102	Serum-and glucocorticoid-inducible kinase SGK 1	B0ONQ7	1-[1-({4-[3-Phenyl-7-(2H-1,2,3,4-tetrazol-5-yl)quinoxalin-2-yl]phenyl}methyl)piperidin-4-yl]-2,3-dihydro-1H-1,3-benzodiazol-2-one	Investigative	10312133	C34H29N9O	579.7	C1CN(CCC1N2C3=CC=CC=C3NC2=O)CC4=CC=C(C=C4)C5=NC6=C(C=CC(=C6)C7=NNN=N7)N=C5C8=CC=CC=C8	IC50 ~ 50000 nM	Poor binder
T64102	Serum-and glucocorticoid-inducible kinase SGK 1	B0P6NT	N-(4-Methoxyphenyl)-2-[4-(4-nitrophenyl)-1,3-thiazol-2-yl]acetamide	Investigative	2958682	C18H15N3O4S	369.4	COC1=CC=C(C=C1)NC(=O)CC2=NC(=CS2)C3=CC=C(C=C3)[N+](=O)[O-]	IC50 = 60000 nM	Poor binder
T64102	Serum-and glucocorticoid-inducible kinase SGK 1	B0T6PL	9-Phenyl-8-(4-((4-(5-(pyridin-2-yl)-1H-1,2,4-triazol-3-yl)piperidin-1-yl)methyl)phenyl)-[1,2,4]triazolo[3,4-f][1,6]naphthyridine-3-thiol	Investigative	15979151	C34H29N9S	595.7	C1CN(CCC1C2=NC(=NN2)C3=CC=CC=N3)CC4=CC=C(C=C4)C5=C(C=C6C(=N5)C=CN7C6=NNC7=S)C8=CC=CC=C8	IC50 ~ 50000 nM	Poor binder
T64102	Serum-and glucocorticoid-inducible kinase SGK 1	B21HEI	3-((4-Methylpiperazin-1-yl)methyl)-9-phenyl-8-(4-((4-(5-(pyridin-2-yl)-1H-1,2,4-triazol-3-yl)piperidin-1-yl)methyl)phenyl)-[1,2,4]triazolo[3,4-f][1,6]naphthyridine	Investigative	44572054	C40H41N11	675.8	CN1CCN(CC1)CC2=NN=C3N2C=CC4=NC(=C(C=C43)C5=CC=CC=C5)C6=CC=C(C=C6)CN7CCC(CC7)C8=NC(=NN8)C9=CC=CC=N9	IC50 ~ 50000 nM	Poor binder
T64102	Serum-and glucocorticoid-inducible kinase SGK 1	B2X1MH	N-Methyl-6-phenyl-7-[4-({4-[5-(pyridin-2-yl)-4H-1,2,4-triazol-3-yl]piperidin-1-yl}methyl)phenyl]pyrido[2,3-d]pyrimidin-2-amine	Investigative	11664023	C33H31N9	553.7	CNC1=NC2=NC(=C(C=C2C=N1)C3=CC=CC=C3)C4=CC=C(C=C4)CN5CCC(CC5)C6=NC(=NN6)C7=CC=CC=N7	IC50 ~ 50000 nM	Poor binder
T64102	Serum-and glucocorticoid-inducible kinase SGK 1	B3RAE6	3-(5-Chloro-2-{[1-(dimethylamino)propan-2-yl]oxy}phenyl)-1-(5-cyanopyrazin-2-yl)urea	Investigative	11417488	C17H19ClN6O2	374.8	CC(CN(C)C)OC1=C(C=C(C=C1)Cl)NC(=O)NC2=NC=C(N=C2)C#N	IC50 ~ 50000 nM	Poor binder
T64102	Serum-and glucocorticoid-inducible kinase SGK 1	B54URI	2-((9-Phenyl-8-(4-((4-(5-(pyridin-2-yl)-1H-1,2,4-triazol-3-yl)piperidin-1-yl)methyl)phenyl)-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-3-yl)methylamino)ethanol	Investigative	44572055	C37H36N10O	636.7	C1CN(CCC1C2=NC(=NN2)C3=CC=CC=N3)CC4=CC=C(C=C4)C5=C(C=C6C(=N5)C=CN7C6=NN=C7CNCCO)C8=CC=CC=C8	IC50 ~ 50000 nM	Poor binder
T64102	Serum-and glucocorticoid-inducible kinase SGK 1	B73VRK	3-(Chloromethyl)-9-phenyl-8-(4-((4-(5-(pyridin-2-yl)-1H-1,2,4-triazol-3-yl)piperidin-1-yl)methyl)phenyl)-[1,2,4]triazolo[3,4-f][1,6]naphthyridine	Investigative	44572053	C35H30ClN9	612.1	C1CN(CCC1C2=NC(=NN2)C3=CC=CC=N3)CC4=CC=C(C=C4)C5=C(C=C6C(=N5)C=CN7C6=NN=C7CCl)C8=CC=CC=C8	IC50 ~ 50000 nM	Poor binder
T64102	Serum-and glucocorticoid-inducible kinase SGK 1	B86ISA	1-(9-Phenyl-8-(4-((4-(5-(pyridin-2-yl)-1H-1,2,4-triazol-3-yl)piperidin-1-yl)methyl)phenyl)-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-3-yl)urea	Investigative	44572052	C35H31N11O	621.7	C1CN(CCC1C2=NC(=NN2)C3=CC=CC=N3)CC4=CC=C(C=C4)C5=C(C=C6C(=N5)C=CN7C6=NN=C7NC(=O)N)C8=CC=CC=C8	IC50 ~ 50000 nM	Poor binder
T64102	Serum-and glucocorticoid-inducible kinase SGK 1	B90MKA	(+)-(1R,3R)-1-(3-Hydroxy-cyclopentyl)-3-(4-methoxy-phenyl)-7-phenylamino-3,4-dihydro-1H-pyrimido[4,5-d]pyrimidin-2-one	Investigative	9910609	C24H25N5O3	431.5	COC1=CC=C(C=C1)N2CC3=CN=C(N=C3N(C2=O)[C@@H]4CC[C@H](C4)O)NC5=CC=CC=C5	IC50 ~ 125000 nM	Poor binder
T64102	Serum-and glucocorticoid-inducible kinase SGK 1	BAL72D	1-[1-({4-[3-Phenyl-6-(2H-1,2,3,4-tetrazol-5-yl)quinoxalin-2-yl]phenyl}methyl)piperidin-4-yl]-2,3-dihydro-1H-1,3-benzodiazol-2-one	Investigative	10415819	C34H29N9O	579.7	C1CN(CCC1N2C3=CC=CC=C3NC2=O)CC4=CC=C(C=C4)C5=NC6=C(C=C(C=C6)C7=NNN=N7)N=C5C8=CC=CC=C8	IC50 ~ 50000 nM	Poor binder
T64102	Serum-and glucocorticoid-inducible kinase SGK 1	BAX6F9	3-{5-Chloro-2-[(3-methyloxetan-3-yl)methoxy]phenyl}-1-(5-cyanopyrazin-2-yl)urea	Investigative	11406175	C17H16ClN5O3	373.8	CC1(COC1)COC2=C(C=C(C=C2)Cl)NC(=O)NC3=NC=C(N=C3)C#N	IC50 ~ 50000 nM	Poor binder
T64102	Serum-and glucocorticoid-inducible kinase SGK 1	BB51ZY	2-(4-{[4-(2-Oxo-2,3-dihydro-1H-1,3-benzodiazol-1-yl)piperidin-1-yl]methyl}phenyl)-3-phenylquinoxaline-6-carboxylic acid	Investigative	21103197	C34H29N5O3	555.6	C1CN(CCC1N2C3=CC=CC=C3NC2=O)CC4=CC=C(C=C4)C5=NC6=C(C=C(C=C6)C(=O)O)N=C5C7=CC=CC=C7	IC50 ~ 50000 nM	Poor binder
T64102	Serum-and glucocorticoid-inducible kinase SGK 1	BJ8V2B	9-Phenyl-8-(4-((4-(5-(pyridin-2-yl)-1H-1,2,4-triazol-3-yl)piperidin-1-yl)methyl)phenyl)-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-3-amine	Investigative	16091080	C34H30N10	578.7	C1CN(CCC1C2=NC(=NN2)C3=CC=CC=N3)CC4=CC=C(C=C4)C5=C(C=C6C(=N5)C=CN7C6=NN=C7N)C8=CC=CC=C8	IC50 ~ 50000 nM	Poor binder
T64102	Serum-and glucocorticoid-inducible kinase SGK 1	BNIM30	1,2,4-Triazolo[3,4-f][1,6]naphthyridine, 9-phenyl-8-[4-[[4-[5-(2-pyridinyl)-1H-1,2,4-triazol-3-yl]-1-piperidinyl]methyl]phenyl]-	Investigative	15979276	C34H29N9	563.7	C1CN(CCC1C2=NC(=NN2)C3=CC=CC=N3)CC4=CC=C(C=C4)C5=C(C=C6C(=N5)C=CN7C6=NN=C7)C8=CC=CC=C8	IC50 ~ 50000 nM	Poor binder
T64102	Serum-and glucocorticoid-inducible kinase SGK 1	BQ9Y5W	2-[9-(4-Amino-3-methoxyphenyl)-6-oxo-5,11-dihydrobenzo[b][1,4]benzodiazepin-3-yl]-N-(4-morpholin-4-ylphenyl)acetamide	Investigative	44427518	C32H31N5O4	549.6	COC1=C(C=CC(=C1)C2=CC3=C(C=C2)C(=O)NC4=C(N3)C=CC(=C4)CC(=O)NC5=CC=C(C=C5)N6CCOCC6)N	IC50 ~ 50000 nM	Poor binder
T64102	Serum-and glucocorticoid-inducible kinase SGK 1	BS31XL	Merck-22-6	Investigative	10240275	C40H43N7O2	653.8	CCN(CC)CCNC(=O)C1=CC2=C(C=C1)N=C(C(=N2)C3=CC=C(C=C3)CN4CCC(CC4)N5C6=CC=CC=C6NC5=O)C7=CC=CC=C7	IC50 ~ 50000 nM	Poor binder
T64102	Serum-and glucocorticoid-inducible kinase SGK 1	BS7WZ3	3-(4-((4-(2-Oxo-2,3-dihydro-1H-benzo[D]imidazol-1-YL)piperidin-1-YL)methyl)phenyl)-2-phenylquinoxaline-6-carboxylic acid	Investigative	10196532	C34H29N5O3	555.6	C1CN(CCC1N2C3=CC=CC=C3NC2=O)CC4=CC=C(C=C4)C5=NC6=C(C=CC(=C6)C(=O)O)N=C5C7=CC=CC=C7	IC50 ~ 50000 nM	Poor binder
T64102	Serum-and glucocorticoid-inducible kinase SGK 1	BV82UP	3-Methyl-9-phenyl-8-(4-((4-(5-(pyridin-2-yl)-1H-1,2,4-triazol-3-yl)piperidin-1-yl)methyl)phenyl)-[1,2,4]triazolo[3,4-f][1,6]naphthyridine	Investigative	15979148	C35H31N9	577.7	CC1=NN=C2N1C=CC3=NC(=C(C=C32)C4=CC=CC=C4)C5=CC=C(C=C5)CN6CCC(CC6)C7=NC(=NN7)C8=CC=CC=N8	IC50 ~ 50000 nM	Poor binder
T64102	Serum-and glucocorticoid-inducible kinase SGK 1	BV9OQ5	(3Z)-6-(4-Hydroxy-3-methoxyphenyl)-3-{1H-pyrrolo[2,3-b]pyridin-3-ylmethylidene}-2,3-dihydro-1H-indol-2-one	Investigative	10215912	C23H17N3O3	383.4	COC1=C(C=CC(=C1)C2=CC3=C(C=C2)/C(=C/C4=CNC5=C4C=CC=N5)/C(=O)N3)O	IC50 ~ 50000 nM	Poor binder
T64102	Serum-and glucocorticoid-inducible kinase SGK 1	BYA4V6	N-[2-(Diethylamino)ethyl]-2-[4-[[4-(2-oxo-3H-benzimidazol-1-yl)piperidin-1-yl]methyl]phenyl]-3-phenylquinoxaline-6-carboxamide	Investigative	10055074	C40H43N7O2	653.8	CCN(CC)CCNC(=O)C1=CC2=C(C=C1)N=C(C(=N2)C3=CC=CC=C3)C4=CC=C(C=C4)CN5CCC(CC5)N6C7=CC=CC=C7NC6=O	IC50 ~ 50000 nM	Poor binder
T64102	Serum-and glucocorticoid-inducible kinase SGK 1	BZK39Q	9-Phenyl-8-(4-((4-(5-(pyridin-2-yl)-1H-1,2,4-triazol-3-yl)piperidin-1-yl)methyl)phenyl)-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-3-ol	Investigative	15979149	C34H29N9O	579.7	C1CN(CCC1C2=NC(=NN2)C3=CC=CC=N3)CC4=CC=C(C=C4)C5=C(C=C6C(=N5)C=CN7C6=NNC7=O)C8=CC=CC=C8	IC50 ~ 50000 nM	Poor binder
T64102	Serum-and glucocorticoid-inducible kinase SGK 1	D09XIL	Ro-4396686	Investigative	11396738	C24H24FN5O3	449.5	COC1=CC=C(C=C1)N2CC3=CN=C(N=C3N(C2=O)[C@@H]4CC[C@H](C4)O)NC5=CC=C(C=C5)F	IC50 ~ 125000 nM	Poor binder
T64102	Serum-and glucocorticoid-inducible kinase SGK 1	D0D6DH	A-432411	Investigative	10125830	C20H16N2O3	332.4	COC1=C(C=CC(=C1)C2=CC3=C(C=C2)/C(=C/C4=CC=CN4)/C(=O)N3)O	IC50 ~ 50000 nM	Poor binder